Cargando…
Treatment-related toxicity using prostate bed versus prostate bed and pelvic lymph node radiation therapy following radical prostatectomy: A national population-based study
Purpose There is debate about the effectiveness and toxicity of pelvic lymph node (PLN) irradiation in addition to prostate bed radiotherapy when used to treat disease recurrence following radical prostatectomy. We compared toxicity from radiation therapy (RT) to the prostate bed and pelvic lymph no...
Autores principales: | Sujenthiran, Arunan, Parry, Matthew G., Dodkins, Joanna, Nossiter, Julie, Morris, Melanie, Berry, Brendan, Nathan, Arjun, Cathcart, Paul, Clarke, Noel W., Payne, Heather, van der Meulen, Jan, Aggarwal, Ajay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10159812/ https://www.ncbi.nlm.nih.gov/pubmed/37152844 http://dx.doi.org/10.1016/j.ctro.2023.100622 |
Ejemplares similares
-
Robot-assisted radical prostatectomy vs laparoscopic and open retropubic radical prostatectomy: functional outcomes 18 months after diagnosis from a national cohort study in England
por: Nossiter, Julie, et al.
Publicado: (2018) -
Impact of cancer service centralisation on the radical treatment of men with high‐risk and locally advanced prostate cancer: A national cross‐sectional analysis in England
por: Parry, Matthew G, et al.
Publicado: (2019) -
National cohort study comparing severe medium‐term urinary complications after robot‐assisted vs laparoscopic vs retropubic open radical prostatectomy
por: Sujenthiran, Arunan, et al.
Publicado: (2017) -
Risk stratification for prostate cancer management: value of the Cambridge Prognostic Group classification for assessing treatment allocation
por: Parry, M. G., et al.
Publicado: (2020) -
Hospital Quality Factors Influencing the Mobility of Patients for Radical Prostate Cancer Radiation Therapy: A National Population-Based Study
por: Aggarwal, Ajay, et al.
Publicado: (2017)